First US FDA approval of CAR-T therapy hikes expectations for Korean biotech ventures – The Korea Herald
The Korea Herald |
First US FDA approval of CAR–T therapy hikes expectations for Korean biotech ventures
The Korea Herald CAR–T cell therapies are widely expected to form a new wave in the realm of cancer treatments, going beyond traditional methods including surgery, chemotherapy, radiation therapy and targeted therapies — drugs that treat cancer by targeting the … |
